Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6825520 | Schizophrenia Research | 2014 | 7 Pages |
Abstract
MA use is associated with decreased neuronal integrity and viability, specifically in the right ACC and right DLPFC. MA dependence showed active neurodegeneration in the right DLPFC, this was not apparent in the MAP group and may be related to the use of antipsychotic medication in the MAP group. The effects of MA use in MAP suggest that age of initial use presents a mismatch of neuronal plasticity, in frontal white vs. gray matter and duration of use relates to decreased neuronal integrity and viability. Further study is warranted from this initial study of 1H-MRS in MAP, in particular longitudinal assessment of these individuals both neurobiologically (1H-MRS) and clinically - to determine disease progression.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Fleur M. Howells, Anne Uhlmann, Henk Temmingh, Heidi Sinclair, Ernesta Meintjes, Don Wilson, Dan J. Stein,